🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Our study is a prospective double-blind randomized study performed in the E...
Status
Unknown
Location
University of Monastir
Start Date
2019-05-20
Trial ID
NCT04016220
Treatments Being Tested
compare the efficacy and safety of intravenous iron sucrose versus chelated...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05151679
Treatments Being Tested
2.2 Aim(s) of the Research (50 words max): To Compare between crystalloid ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-11
Trial ID
NCT05220891
Treatments Being Tested
The study was planned to compare the effect of ketorolac 20 mg to 300 mg of...
Status
Completed
Location
Omar Ali
Start Date
2018-03-21
Trial ID
NCT03485625
Treatments Being Tested
Autoimmune hepatitis (AIH) is characterized by chronic inflammation of the ...
Status
Unknown
Location
Beijing 302 Hospital
Start Date
2011-10
Trial ID
NCT01661842
Treatments Being Tested
Lurbinectedin is mainly eliminated by the liver. Thus, Hepatic Impairment (...
Status
Unknown
Location
Hospital Universitario Virgen de la Victoria
Start Date
2021-03-09
Trial ID
NCT05101265
Treatments Being Tested
This study consists of a single-dose pilot phase and a randomized, two-way ...
Status
Completed
Location
Simbec Research Limited
Start Date
2014-08
Trial ID
NCT02068235
Treatments Being Tested
This phase 1/2 study will evaluate the safety, tolerance and dose of BM7PE ...
Status
Terminated
Location
Oslo University Hospital
Start Date
2020-08-31
Trial ID
NCT04550897
Treatments Being Tested
Phase I study aiming at: * establishing the pharmacokinetic profile of int...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT02517788
The investigators aim to evaluate whether and to what extent glucose tolera...
Status
Completed
Location
Azienda Ospedaliero-Universitaria Pisana
Start Date
2019-04-30
Trial ID
NCT05181514
Treatments Being Tested